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Sp=61%) and MRI (Se=56% Sp=92%). ROC analysis showed that, in comparison to the
combination of ECG, SAECG, Hol and ETT, the area under the curve did not differ signif-
icantly for their combination with MRI.
Conclusion: This study demonstrates that an ECG offers the highest sensitivity and the
SAECG offers the highest specificity in diagnosing ARVD. MRI offers high specificity but
its combination with the ECG, SAECG, ETT and Hol does not improve the utility of the
other tests significantly. 
1127-105 Transient Left Ventricular Apical Ballooning Syndrome: 
A US Case-Series
Kevin A. Bybee, Abihiram Prasad, Gregory W. Barsness, Joseph G. Murphy, Allan S. 
Jaffe, Amir Lerman, R. Scott Wright, Charanjit S. Rihal, Mayo Clinic and Foundation, 
Rochester, MN
Background: Transient left ventricular apical ballooning syndrome (TLVABS) is a distinct
form of acute reversible left ventricular dysfunction which was initially described in Japan.
It’s frequency and clinical presentation in the U.S. is unclear. This is one of the first
descriptions of the syndrome in a U.S. population.
Methods: We identified 10 patients during the year 2002 who had: 1) apical LV ballooning
with akinesis or dyskinesis extending beyond a single major coronary artery distribution;
2) a coronary angiogram revealing no stenosis greater than 70%; 3) new ST segment/T
wave changes on the presenting electrocardiogram. We investigated the clinical charac-
teristics and short-term outcome of these patients with TLVABS.
Results: All patients were white females; mean age 71.5+12.0 years. Presenting symp-
toms were chest pain in 5, dyspnea in 3, and chest pain and dyspnea in 2 patients. Eight
had at least 1 mm of ST elevation in contiguous leads, typically V2-V5. The QTc was >
500ms in seven patients with a mean QTc of 519 ms+50 ms for all patients. All patients
had troponin T and/or CK-MB elevations. The highest recorded median peak troponin T
and CK-MB values were 0.59 ng/ml (25th-75th percentile 0.33-0.93 ng/ml) and 14.1ng/ml
(9.7-26.9 ng/ml), respectively. An identifiable preceding acute emotional or physiologic
stressor was present in 8 of 10 patients. All coronary stenosis in patients with CAD were
< 50%, except for 1 patient with a chronic 60% mid-LAD lesion. The mean LVEF at
admission was 44.8+10.2%, which improved to 58.4+11.9% at follow-up (22+41 days);
p=0.004. All 7 patients with available follow-up had resolution of wall motion abnormali-
ties (29+45 days). Five patients developed left heart failure requiring treatment. All
patients were alive at a median follow-up of 6.5 months (range 1-17 months).
Conclusion: This is one of the first series reporting TLVABS in a US population. TLVABS
can mimic AMI with ECG changes, elevation of cardiac biomarkers, associated left ven-
tricular dysfunction and in some, clinical heart failure. The short-term prognosis appears
favorable with resolution of LV dysfunction. Further studies including long-term follow-up
are needed.
1127-106 Usefulness of Tissue Doppler Imaging for Evaluating 
Systolic and Diastolic Left Ventricular Function in 
Patients With Primary Cardiac Amyloidosis
Jing Ping Sun, John A. Sallach, Neil L. Greenberg, William J. Stewart, Gordan Srkalovic, 
James D. Thomas, Allan L. Klein, The Cleveland Clinic Foundation, Cleveland, OH
Background: Cardiac amyloidosis is associated with increased left ventricular (LV) wall
thickness, normal or decreased LV cavity size, and congestive heart failure (CHF) with
normal or mildly reduced LV ejection fraction. Aim:To clarify whether tissue Doppler
imaging at multiple left ventricular LV sites could help estimate LV systolic and diastolic
function in patients with primary amyloidosis. Methods and Results: Standard 2-D, Dop-
pler and tissue Doppler echocardiographic study was performed in 12 consecutive
patients with primary amyloidosis confirmed by biopsy and 12 matched (age 62±14, 8
males in both groups) normal volunteers. The data were on-line or off-line analyzed using
Vivid 7, GE and Echo Pac. The parameters are present average segmental values as
mean±SD, T test was used for comparison. The diastolic functions of patients with pri-
mary amyloidosis were abnormal (6 were relaxation impaired; 3 were seudonormal; and
4 were restrictive). Tissue Doppler data were different between three types, but not sig-
nificantly; which may due to limited cases number. 
IST=interventricular septal thickness, PWT=LV posterior wall thickness, LV EF=LV ejec-
tion fraction. TK=myocardial displacement, STRs=systolic strain rate, STR=strain rate.
Conclusion: Cardiac amyloidosis is charaterized.by an early impaired in systolic and 
diastolic function. These abnormalities precedes the onset of congestive heart failure 
and can be detected by tissue Doppler velocity, displacement, strain rate and strain 
1127-107 Different Criteria of Cardiac Resynchronization Therapy 
Have Different Prognostic Value for Worsening Heart 
Failure or Major Arrhythmic Events in Idiopathic Dilated 
Cardiomyopathy
Laurent Fauchier, Julien Douglas, Dominique Babuty, Olivier Marie, Pierre Cosnay, Pierre 
Bonnet, Jean Paul Fauchier, Centre Hospitalier Universitaire Trousseau, Tours, France
Cardiac resynchronization therapy (CRT) with biventricular pacing (biV) improves cardiac
symptoms in heart failure patients with dilated cardiomyopathy. There are still controver-
sies about pertinent criteria for CRT and about prophylactic indications of biV cardio-
verter defibrillator.
Methods. In 201 patients with idiopathic dilated cardiomyopathy (IDC) in sinus rhythm
(WHO criteria; age 51±12 years; left ventricular ejection fraction 32±12%), the relative
risk of 1) cardiac death due to heart failure or heart transplantation and 2) sudden death
or sustained ventricular tachycardia (VT) or fibrillation (VF) were calculated separately
according to the inclusion criteria in the MUSTIC, InSync, MIRACLE and CONTAK stud-
ies.
Results. The percentage of patients meeting the inclusion criteria was respectively 6%
for MUSTIC, 7.5 % for InSync, 10 % for MIRACLE and 23 % for CONTAK. With a follow-
up of 51±42 months, 28 patients suffered cardiac death (15 progressive CHF, 13 sudden
deaths), 20 underwent heart transplantation and 12 had sustained VT/VF. Relative risks
of events are in table. Major arrhythmic events were 16 % of all the cardiac events for the
MUSTIC patients, 11% for InSync, 36 % for MIRACLE and 42 % for CONTAK.
Conclusion. In IDC, the patients with the less restrictive inclusion criteria of CRT had the
highest risk of major arrhythmic events. By contrast, severe HF patients with the MUSTIC
criteria of CRT mainly had a risk of worsening heart failure and may not benefit from biV
cardiverter defibrillator.
1127-108 Characteristics of Takotsubo Cardiomyopathy: First US 
Population-Based Report
Amish J. Desai, Milind R. Dhond, Mary Rose Fabi, Richard J. Valente, Ezra A. 
Amsterdam, University of California, Davis, Sacramento, CA
Background: Takotsubo Cardiomyopathy (TC) has been previously described in the Jap-
anese and more recently European literature.This is the first report of this condition in a
US population. TC is characterized by (1) suspected acute MI based on symptoms, elec-
trocardiographic (ECG) changes, and increased cardiac serum markers; (2) hyokinesis/
akinesis of mid to apical left ventricle (LV) and hyperkinesis of the basal LV on ventricu-
lography, (3) < 75% stenoses in the major coronary arteries, and (4) improvement of LV
function on follow-up.
Methods: From January 2002-August 2003 we admitted 9 patients with features consis-
tent with TC. All patients met all 4 criteria for the diagnosis of TC. Data on prestentation
included patient characteristics, complete hemodynamic assessment, coronary and LV
angiography and echocardiography.
Results: Mean patient age was 60.5 years, and 6 were women (66%). Cardiac risk fac-
tors: 7/9 (78%) had hypertension, 2/9 (22%) had diabetes, 2/9 (22%) were smokers, 2/9
(22%) had a family history of premature coronary heart disease, and 3/9 (33%) had
treated hypothyroidism. ECG revealed ST elevation in 3/9 (33%), and T wave changes in
6/9 (66%). At presentation, mean ejection fraction was 32.5%, mean wedge pressure
was 12.7 mm Hg and cardiac output of 3.14 L/min. 8/9 (88%) patients had physiologic
stressors at the time of presentation with 1/9 having an intense emotional stressor. Coro-
nary angiography was normal in all patients and left ventriculography revealed the char-
acteristic Takotsubo (octopus trap) shape. At a mean follow-up of 6 + 2 months all
patients were alive with a mean EF of 49%.
Conclusions: Takotsubo Cardiomyopathy is an unusual and probably underdiagnosed
entity. Our data from the first American cohort confirm prior reports of a clinical presenta-
Standard 
Echo LVD(cm) IST(cm) PWT(c
m)
 EF(%)
LAarea 
(cm2) DT(msec) E/Amitral
Normal 4.7±0.6 1.0±0.2 1.0±0.2 64±7 16±4 201±28 1.2±0.5
Amyoloid 4.0±0.7 1.8±0.2 1.7±0.4 57±3 25±7 167±54 1.9±1.0
p 0.02 <0.0001 <0.0001 0.02 <0.0001 0.10 0.12
Tissue 
Doppler 
Echo
LVS 
velocity(cm/
sec)
LV 
velocityE/
A
LVTK(c
m)
STRs(1/
s)
LV 
STRE/A
LV Systolic 
Strain (%) LV 
StrainE/
A
Normal 4.5±1.0 1.9±1.2 0.8±0.2 -1.1±0.3 1.6±0.4 -19±4 1.6±1.1
Amyoloid 3.0±1.4 4.4±1.9 0.4±0.2 -0.8±0.4 3.5±3.2 -10±5 2.7±0.8
p 0.01 0.01 <0.0001 0.02 0.04 <0.0001 0.01
NYH
A
LV EDD LV EF QRS RR (95% CI) HF 
events
p RR (95% CI) 
Arrhythmic events
p
MUSTIC III >60 mm <35 % >150 ms 4.63 (1.76-12.19) 0.0019 1.16 (0.15-8.70) 0.89
InSync III-IV >60 mm <35 % >150 ms 4.27 (1.85-9.90) 0.0007 1.45 (0.19-11.10) 0.72
MIRACLE III-IV >55 mm <35 % >130 ms 3.14 (1.41-6.99) 0.005 1.83 (0.63-5.35) 0.55
CONTAK II-IV <35 % >120 ms 3.67 (1.85-7.29) 0.0002 2.65 (1.19-5.95) 0.018
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tion suggesting an acute coronary syndrome with impaired LV function but without coro-
nary disease. It is associated with substantial recovery of LV ejection fraction, resolution
of LV wall motion abnormalities and an excellent short-term prognosis.
1127-133 Clinical and Pathologic Characteristics of Dilated 
Cardiomyopathy in Dialysis Patients
Jiro Aoki, Yuji Ikari, Hiroyoshi Nakajima, Masaya Mori, Tokuichiro Sugimoto, Kazuhiro 
Hara, Mitsui Memorial Hospital, Tokyo, Japan
Background Some dialysis patients have impaired left ventricular (LV) function without
coronary artery disease. The pathologic changes of these patients have not been well
described. This study evaluated the clinical and pathologic characteristics of dialysis
patients with dilated cardiomyopathy (DCM). Methods We performed LV endomyocardial
biopsy on 40 dialysis patients with DCM. After LV biopsy, the patients were followed up
for mean 2.3±1.9 years. Results The pathologic characteristics were severe myocyte
hypertrophy (the mean myocyte diameter across the nucleus was 37.6±10.5 µm), myo-
cyte disarray (30%), and extensive fibrosis (the mean percent area of left ventricular
fibrosis was 22.3±18.4%). These pathologic characteristics resembled the dilated phase
of hypertophic cardiomyopathy. Their two-year survival rate was 72%. A high percent
area of LV fibrosis was the only significant predictor of cardiac death by multivariate anal-
ysis (p=0.03). The two-year event-free survival rate for cardiac death in patients with
severe fibrosis (more than 30%) was 42%, while that for patients without severe fibrosis
was 92%. Conclusion The pathologic characteristics of the heart in dialysis patients with
DCM are severe myocyte hypertrophy occasionally with disarray and a high percent area
of fibrosis. The prognosis of these patients was poor and the extent of LV fibrosis was a
strong predictor of cardiac death.
1127-134 Noninvasive Determination of Central Venous Pressure 
With a Bedside Ultrasound Device
Kelley R. Branch, Deborah H. Kwon, John M. Nicklas, University of Michigan, Ann Arbor, 
MI, University of Washington, Seattle, WA
Background: In patients with heart failure, clinical signs may not accurately reflect
hemodynamic abnormalities. To improve clinical assessment of central venous pressure
(CVP), we used a bedside ultrasound device to measure internal jugular (IJ) distention.
Methods: Forty-five subjects referred for right heart catheterization underwent cross-
sectional IJ imaging with a Site-Rite ultrasonic device (Dymax, Pittsburgh, PA). Biphasic
pulsatile distention (BiP) of an IJ, corresponding to a and v venous waves, was examined
in 36 patients. If present [(+) BiP], the maximal vertical height of the IJ fluid column was
measured from the clavicle to where the BiP disappeared while sitting upright. CVP was
measured directly by right heart catheterization and compared to the IJ ultrasound data.
Results: In patients with a measured CVP <7 mmHg, IJ BiP was not observed. In those
with a CVP >7 mmHg, BiP was present in most, but not all patients. Sensitivity for CVP
detection was 61% and specificity was 100%. The ultrasound-measured vertical IJ height
was statistically related to CVP (p = 0.006), but the correlation was poor (R2 = 0.41).
Conclusions: The absence of IJ BiP distention by cross-sectional ultrasonography while
sitting upright is a highly specific predictor of low CVP (< 7 mmHg). In patients with ele-
vated CVP, ultrasound assessment of IJ vertical distention correlates poorly with mea-
sured CVP. This demonstrates a novel, non-invasive, and readily available method for
estimation of right-sided filling pressures.
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1128-119 Coronary Flow Velocity Reserve and Asymmetric 
Dimethylarginine in Patients With Type 2 Diabetes 
Mellitus
Takayuki Kawata, Masao Daimon, Rei Hasegawa, Tomohiko Toyoda, Tai Sekine, Sachiko 
Honjyo, Kyouhei Yamamoto, Daigaku Uchida, Toshiharu Himi, Katsuya Yoshida, Issei 
Komuro, Chiba University, Chiba, Japan, Kimitsu Chuo Hospital, Chiba, Japan
Background: Endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine
(ADMA) is elevated and coronary flow velocity reserve (CFVR) is attenuated in patients
with diabetes mellitus. Although ADMA has been considered as a novel marker of athero-
sclerosis, no clinical report has yet examined the relation between ADMA and coronary
microcirculation in diabetes mellitus. We aimed to assess the relation between serum
levels of ADMA and coronary microcirculation in patients with type 2 diabetes mellitus,
using CFVR measurements with noninvasive transthoracic Doppler echocardiography
(TTDE). Methods: We studied 21 patients with type 2 diabetes mellitus (mean age
62±10 years; 12 men and 9 women, body mass index 23±4). Coronary flow velocities in
the left anterior descending artery were recorded with TTDE at rest and during hypere-
mia induced by intravenous infusion of adenosine triphosphate. CFVR was calculated as
the ratio of hyperemic to basal mean diastolic velocity. We analyzed relationship between
CFVR and venous blood samples. Results: Obtained data were as follows; CFVR
2.78±0.56, Fasting blood sugar 171±37 mg/dl, HbA1c 7.6±1.0%, Total-cholesterol
198±42 mg/dl, Triglycerides 125±78 mg/dl, HDL-cholesterol 53±15 mg/dl, and ADMA
0.5±0.08 nmol/ml. Only serum ADMA level and CFVR had significant inverse correlation
(r=-0.55, p<0.01). Moreover, multiple regression analysis showed serum ADMA level was
independently associated with CFVR (β=-0.69, p<0.01). Conclusions: This result sug-
gests that CFVR related to a serum level of ADMA. Measurement of ADMA is useful to
speculate coronary microcirculation in patients with type 2 diabetes mellitus.
1128-120 Importance of an Oral Glucose Tolerance Test in 
Identifying High Prevalence of Dysglycemia in 
Individuals at High Cardiovascular Risk
Koon K. Teo, Salim Yusuf, Barbara Ramos, Feng Zhao, Lutz Hilbrich, Craig Anderson, 
Peter Sleight, The ONTARGET/TRANSCEND Investigators, McMaster University, 
Hamilton, ON, Canada
Background Diabetes mellitus (DM) is an important cardiovascular risk factor, but
impaired glucose metabolism short of frank DM also carries excess risk. Dysglycemia
comprises (a) DM - fasting plasma glucose level =/>7 mmol/L or 2-hour glucose level
>11.1 mmol/L after a 75 gm glucose load during an oral glucose tolerance test (OGTT),
(b) impaired glucose tolerance (IGT) - fasting plasma glucose < 7 mmol/L but 2 hour glu-
cose level between 7.8 to 11.0 mmol/L during a routine OGTT, and (c) impaired fasting
glucose (IFG) - between 6.1 and 6.9 mmol/L.
Methods In this study a 2-hour 75 gm glucose load OGTT was performed, at baseline, in
consecutive patients who do not have a history of DM, enrolled into a large clinical trial.
The TRANSCEND trial includes patients, 55 years or older, at high risk for cardiovascular
events who are intolerant to ACE inhibitors, and who had been randomized to an angio-
tensin II receptor blocker, telmisartan or to placebo.
Results Of 1327 patients studied, 289 (21.8%) patients had a history of DM, an addi-
tional 121 (9.3%) patients were diagnosed to have DM during the routine baseline OGTT,
208 (15.7%) patients had IGT, 58 (4.4%) patients had IFG and 54 (4.1%) patients
refused the OGTT. Thus, at least 52.2% of the 1327 subjects have dysglycemia. History
alone identified less than half of these cases whereas a routine OGTT has been found
useful in identifying a substantial additional number of these high risk middle-aged indi-
viduals who did not know that they had abnormal glucose metabolism.
Conclusion The prevalence of dysglycemia in high-risk middle-aged individuals is higher
than generally believed and can only be identified with a routine OGTT. The identification
of dysglycemia and management of these individuals by appropriate preventive mea-
sures should contribute to a reduction of their risks.
1128-121 Manganese Superoxide Dismutase Alanine/Valine 
Polymorphism Is Associated With Coronary Artery 
Disease
Hajime Fujimoto, Nobukazu Ishizaka, Minoru Ohno, Minoru Yamakado, Ryozo Nagai, 
University of Tokyo, Tokyo, Japan, Mitsui Memorial Hospital, Tokyo, Japan
Background: Oxidative stress plays an important role in atherogenesis. Manganese
superoxide dismutase (MnSOD) is an antioxidative enzyme localized in the mitochondria.
Today, two MnSOD genotypes are known; GTT (valine) to GCT (alanine) substitution in
an amino acid codon in the signal peptide. This substitution is thought to alter the trans-
port of MnSOD into the mitochondrion, and its efficacy in fighting oxidative stress. We
investigated the association between MnSOD genotype and coronary artery disease
(CAD). Methods and Results: Blood samples were collected from 616 healthy subjects
and 442 CAD patients (those who had >75 percent diametric stenosis in their coronary
arteries) diagnosed by coronary angiography. MnSOD genotype was analyzed by fluo-
rescence-based allele-specific polymerase chain reaction and melting curve analysis
(LightCycler). The valine allele frequency was higher in the CAD patients (0.89) than in
the healthy subjects (0.84) (odds ratio=1.54, P=0.0006, Table). MnSOD polymorphism
(alanine/alanine, alanine/valine, or valine/valine) was closely related with CAD (P=0.001
by chi-square analysis, Table), but had no association with other coronary risk factors.
From multivariate logistic regression analysis, valine/valine genotype was shown to be a
coronary risk factor independent of other risk factors (odds ratio=1.76, P=0.003). Conclu-
sion: Valine allele is closely related to the susceptibility of CAD. The valine/valine geno-
type of MnSOD is a genetic risk factor for CAD.
CVP<7 (n, %) CVP>7 (n, %)
(+) BiP 0 (0%) 17 (61%)
(-) BiP 17 (100%) 11 (39%)
Total 17 28
Genotype Healthy 
Subjects (616)
CAD Subjects 
(442)
P value
val/val, % (n) 69.8 (430) 79.8 (353) 0. 001
(chi-square 
analysis)
ala/val, % (n) 28.3 (174) 18.6 (82)
ala/ala, % (n) 1.9 (12) 1.6 (7)
Allele frequency of ala and 
val (ala / val)
0.16 / 0.84 0.11 / 0.89 0. 0006 (unpaired 
t-test)
